Skip to main content
Top
Published in: EJNMMI Research 1/2021

Open Access 01-12-2021 | Positron Emission Tomography | Original research

Prospective data-driven respiratory gating of [68Ga]Ga-DOTATOC PET/CT

Authors: Jonathan Sigfridsson, Elin Lindström, Victor Iyer, Maria Holstensson, Irina Velikyan, Anders Sundin, Mark Lubberink

Published in: EJNMMI Research | Issue 1/2021

Login to get access

Abstract

Aim

The aim of this prospective study was to evaluate a data-driven gating software’s performance, in terms of identifying the respiratory signal, comparing [68Ga]Ga-DOTATOC and [18F]FDG examinations. In addition, for the [68Ga]Ga-DOTATOC examinations, tracer uptake quantitation and liver lesion detectability were assessed.

Methods

Twenty-four patients with confirmed or suspected neuroendocrine tumours underwent whole-body [68Ga]Ga-DOTATOC PET/CT examinations. Prospective DDG was applied on all bed positions and respiratory motion correction was triggered automatically when the detected respiratory signal exceeded a certain threshold (R value ≥ 15), at which point the scan time for that bed position was doubled. These bed positions were reconstructed with quiescent period gating (QPG), retaining 50% of the total coincidences. A respiratory signal evaluation regarding the software’s efficacy in detecting respiratory motion for [68Ga]Ga-DOTATOC was conducted and compared to [18F]FDG data. Measurements of SUVmax, SUVmean, and tumour volume were performed on [68Ga]Ga-DOTATOC PET and compared between gated and non-gated images.

Results

The threshold of R ≥ 15 was exceeded and gating triggered on mean 2.1 bed positions per examination for [68Ga]Ga-DOTATOC as compared to 1.4 for [18F]FDG. In total, 34 tumours were evaluated in a quantitative analysis. An increase of 25.3% and 28.1%, respectively, for SUVmax (P < 0.0001) and SUVmean (P < 0.0001), and decrease of 21.1% in tumour volume (P < 0.0001) was found when DDG was applied.

Conclusions

High respiratory signal was exclusively detected in bed positions where respiratory motion was expected, indicating reliable performance of the DDG software on [68Ga]Ga-DOTATOC PET/CT. DDG yielded significantly higher SUVmax and SUVmean values and smaller tumour volumes, as compared to non-gated images.
Literature
1.
go back to reference Visvikis D, Lamare F, Bruyant P, Boussion N, Cheze Le Rest C. Respiratory motion in positron emission tomography for oncology applications: Problems and solutions. Nucl Instruments Methods Phys Res Sect A Accel Spectrometers Detect Assoc Equip. 2006;569(2):453–7.CrossRef Visvikis D, Lamare F, Bruyant P, Boussion N, Cheze Le Rest C. Respiratory motion in positron emission tomography for oncology applications: Problems and solutions. Nucl Instruments Methods Phys Res Sect A Accel Spectrometers Detect Assoc Equip. 2006;569(2):453–7.CrossRef
2.
go back to reference Nehmeh SA, Erdi YE. Respiratory motion in positron emission tomography/computed tomography: a review. Semin Nucl Med. 2008;38(3):167–76.CrossRef Nehmeh SA, Erdi YE. Respiratory motion in positron emission tomography/computed tomography: a review. Semin Nucl Med. 2008;38(3):167–76.CrossRef
3.
go back to reference Grootjans W, de Geus-Oei LF, Meeuwis APW, et al. Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer. Eur Radiol. 2014;24(12):3242–50.CrossRef Grootjans W, de Geus-Oei LF, Meeuwis APW, et al. Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer. Eur Radiol. 2014;24(12):3242–50.CrossRef
4.
go back to reference Nehmeh SA, Erdi YE, Ling CC, et al. Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer. Med Phys. 2002;29(3):366–71.CrossRef Nehmeh SA, Erdi YE, Ling CC, et al. Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer. Med Phys. 2002;29(3):366–71.CrossRef
5.
go back to reference Pépin A, Daouk J, Bailly P, Hapdey S, Meyer ME. Management of respiratory motion in PET/computed tomography: the state of the art. Nucl Med Commun. 2014;35(2):113–22.CrossRef Pépin A, Daouk J, Bailly P, Hapdey S, Meyer ME. Management of respiratory motion in PET/computed tomography: the state of the art. Nucl Med Commun. 2014;35(2):113–22.CrossRef
6.
go back to reference Fayad H, Pan T, Franois Clement J, Visvikis D. Technical Note: Correlation of respiratory motion between external patient surface and internal anatomical landmarks. Med Phys. 2011;38(6):3157–64.CrossRef Fayad H, Pan T, Franois Clement J, Visvikis D. Technical Note: Correlation of respiratory motion between external patient surface and internal anatomical landmarks. Med Phys. 2011;38(6):3157–64.CrossRef
7.
go back to reference Ozhasoglu C, Murphy MJ. Issues in respiratory motion compensation during external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52(5):1389–99.CrossRef Ozhasoglu C, Murphy MJ. Issues in respiratory motion compensation during external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52(5):1389–99.CrossRef
8.
go back to reference He J, O’Keefe GJ, Gong SJ, et al. A novel method for respiratory motion gated with geometric sensitivity of the scanner in 3D PET. IEEE Trans Nucl Sci. 2008;55(5):2557–65.CrossRef He J, O’Keefe GJ, Gong SJ, et al. A novel method for respiratory motion gated with geometric sensitivity of the scanner in 3D PET. IEEE Trans Nucl Sci. 2008;55(5):2557–65.CrossRef
9.
go back to reference Büther F, Dawood M, Stegger L, et al. List mode-driven cardiac and respiratory gating in PET. J Nucl Med. 2009;50(5):674–81.CrossRef Büther F, Dawood M, Stegger L, et al. List mode-driven cardiac and respiratory gating in PET. J Nucl Med. 2009;50(5):674–81.CrossRef
10.
go back to reference Kesner AL, Kuntner C. A new fast and fully automated software based algorithm for extracting respiratory signal from raw PET data and its comparison to other methods. Med Phys. 2010;37(10):5550–9.CrossRef Kesner AL, Kuntner C. A new fast and fully automated software based algorithm for extracting respiratory signal from raw PET data and its comparison to other methods. Med Phys. 2010;37(10):5550–9.CrossRef
11.
go back to reference Thielemans K, Rathore S, Engbrant F, Razifar P. Device-less gating for PET/CT using PCA. In: 2011 IEEE nuclear science symposium conference record. IEEE; 2011:3904–3910 Thielemans K, Rathore S, Engbrant F, Razifar P. Device-less gating for PET/CT using PCA. In: 2011 IEEE nuclear science symposium conference record. IEEE; 2011:3904–3910
12.
go back to reference Schleyer PJ, O’Doherty MJ, Barrington SF, Marsden PK. Retrospective data-driven respiratory gating for PET/CT. Phys Med Biol. 2009;54(7):1935–50.CrossRef Schleyer PJ, O’Doherty MJ, Barrington SF, Marsden PK. Retrospective data-driven respiratory gating for PET/CT. Phys Med Biol. 2009;54(7):1935–50.CrossRef
13.
go back to reference Thielemans K, Schleyer P, Marsden PK, Manjeshwar RM, Wollenweber SD, Ganin A. Comparison of different methods for data-driven respiratory gating of PET data. In: IEEE nuclear science symposium conference record. IEEE; 2013. Thielemans K, Schleyer P, Marsden PK, Manjeshwar RM, Wollenweber SD, Ganin A. Comparison of different methods for data-driven respiratory gating of PET data. In: IEEE nuclear science symposium conference record. IEEE; 2013.
14.
go back to reference Walker MD, Morgan AJ, Bradley KM, McGowan DR. Evaluation of data-driven respiratory gating waveforms for clinical PET imaging. EJNMMI Res. 2019. Walker MD, Morgan AJ, Bradley KM, McGowan DR. Evaluation of data-driven respiratory gating waveforms for clinical PET imaging. EJNMMI Res. 2019.
15.
go back to reference Walker MD, Morgan AJ, Bradley KM, McGowan DR. Data Driven Respiratory Gating Outperforms Device-Based Gating for Clinical FDG PET/CT. J Nucl Med. Published online April 3, 2020:jnumed.120.242248. Walker MD, Morgan AJ, Bradley KM, McGowan DR. Data Driven Respiratory Gating Outperforms Device-Based Gating for Clinical FDG PET/CT. J Nucl Med. Published online April 3, 2020:jnumed.120.242248.
16.
go back to reference Kang SY, Moon BS, Kim HO, Yoon HJ, Kim BS. The impact of data-driven respiratory gating in clinical F-18 FDG PET/CT: comparison of free breathing and deep-expiration breath-hold CT protocol. Ann Nucl Med. 2021;35(3):328–37.CrossRef Kang SY, Moon BS, Kim HO, Yoon HJ, Kim BS. The impact of data-driven respiratory gating in clinical F-18 FDG PET/CT: comparison of free breathing and deep-expiration breath-hold CT protocol. Ann Nucl Med. 2021;35(3):328–37.CrossRef
17.
go back to reference Schleyer PJ, Thielemans K, Marsden PK. Extracting a respiratory signal from raw dynamic PET data that contain tracer kinetics. Phys Med Biol. 2014;59(15):4345–56.CrossRef Schleyer PJ, Thielemans K, Marsden PK. Extracting a respiratory signal from raw dynamic PET data that contain tracer kinetics. Phys Med Biol. 2014;59(15):4345–56.CrossRef
18.
go back to reference Graham MM, Gu X, Ginader T, Breheny P, Sunderland JJ. 68Ga-DOTATOC imaging of neuroendocrine tumors: a systematic review and metaanalysis. J Nucl Med. 2017;58(9):1452–8.CrossRef Graham MM, Gu X, Ginader T, Breheny P, Sunderland JJ. 68Ga-DOTATOC imaging of neuroendocrine tumors: a systematic review and metaanalysis. J Nucl Med. 2017;58(9):1452–8.CrossRef
19.
go back to reference Hofmann M, Maecke H, Börner AR, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med. 2001;28(12):1751–7.CrossRef Hofmann M, Maecke H, Börner AR, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med. 2001;28(12):1751–7.CrossRef
20.
go back to reference Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.CrossRef Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.CrossRef
21.
go back to reference Geramizadeh B, Kashkooe A, Malekhosseini SA. Liver metastasis of gastrointestinal neuroendocrine tumors: a single center experience. Hepat Mon. 2016;16(5):2014–7.CrossRef Geramizadeh B, Kashkooe A, Malekhosseini SA. Liver metastasis of gastrointestinal neuroendocrine tumors: a single center experience. Hepat Mon. 2016;16(5):2014–7.CrossRef
22.
go back to reference Kwekkeboom D, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med. 2000;41(10):1704–13.PubMed Kwekkeboom D, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med. 2000;41(10):1704–13.PubMed
23.
go back to reference Kam BLR, Teunissen JJM, Krenning EP, et al. Lutetium-labelled peptides for therapy of neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2012;39(Suppl. 1):S103.CrossRef Kam BLR, Teunissen JJM, Krenning EP, et al. Lutetium-labelled peptides for therapy of neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2012;39(Suppl. 1):S103.CrossRef
24.
go back to reference Kratochwil C, Stefanova M, Mavriopoulou E, et al. SUV of [68Ga]DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors. Mol Imaging Biol. 2015;17(3):313–8.CrossRef Kratochwil C, Stefanova M, Mavriopoulou E, et al. SUV of [68Ga]DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors. Mol Imaging Biol. 2015;17(3):313–8.CrossRef
25.
go back to reference Öksüz MÖ, Winter L, Pfannenberg C, et al. Peptide receptor radionuclide therapy of neuroendocrine tumors with 90Y-DOTATOC: is treatment response predictable by pre-therapeutic uptake of 68Ga-DOTATOC? Diagn Interv Imaging. 2014;95(3):289–300.CrossRef Öksüz MÖ, Winter L, Pfannenberg C, et al. Peptide receptor radionuclide therapy of neuroendocrine tumors with 90Y-DOTATOC: is treatment response predictable by pre-therapeutic uptake of 68Ga-DOTATOC? Diagn Interv Imaging. 2014;95(3):289–300.CrossRef
26.
go back to reference Liberini V, Kotasidis F, Treyer V, et al. Impact of PET data driven respiratory motion correction and BSREM reconstruction of 68Ga-DOTATATE PET/CT for differentiating neuroendocrine tumors (NET) and intrapancreatic accessory spleens (IPAS). Sci Rep. 2021;11(1):1–13.CrossRef Liberini V, Kotasidis F, Treyer V, et al. Impact of PET data driven respiratory motion correction and BSREM reconstruction of 68Ga-DOTATATE PET/CT for differentiating neuroendocrine tumors (NET) and intrapancreatic accessory spleens (IPAS). Sci Rep. 2021;11(1):1–13.CrossRef
Metadata
Title
Prospective data-driven respiratory gating of [68Ga]Ga-DOTATOC PET/CT
Authors
Jonathan Sigfridsson
Elin Lindström
Victor Iyer
Maria Holstensson
Irina Velikyan
Anders Sundin
Mark Lubberink
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
Published in
EJNMMI Research / Issue 1/2021
Electronic ISSN: 2191-219X
DOI
https://doi.org/10.1186/s13550-021-00775-w

Other articles of this Issue 1/2021

EJNMMI Research 1/2021 Go to the issue